LU83052A1 - Composition pharmaceutique a effet prolonge et son procede de preparation - Google Patents

Composition pharmaceutique a effet prolonge et son procede de preparation Download PDF

Info

Publication number
LU83052A1
LU83052A1 LU83052A LU83052A LU83052A1 LU 83052 A1 LU83052 A1 LU 83052A1 LU 83052 A LU83052 A LU 83052A LU 83052 A LU83052 A LU 83052A LU 83052 A1 LU83052 A1 LU 83052A1
Authority
LU
Luxembourg
Prior art keywords
agent
release
composition according
amount
tablets
Prior art date
Application number
LU83052A
Other languages
English (en)
French (fr)
Inventor
James Michael Dunn
John Francis Lampard
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of LU83052A1 publication Critical patent/LU83052A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU83052A 1980-01-11 1981-01-09 Composition pharmaceutique a effet prolonge et son procede de preparation LU83052A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US11143080 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments
US19445380 1980-10-17

Publications (1)

Publication Number Publication Date
LU83052A1 true LU83052A1 (fr) 1982-09-10

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83052A LU83052A1 (fr) 1980-01-11 1981-01-09 Composition pharmaceutique a effet prolonge et son procede de preparation

Country Status (22)

Country Link
JP (1) JPS56103110A (fi)
AT (1) AT374681B (fi)
AU (1) AU542824B2 (fi)
BE (1) BE886998A (fi)
CA (1) CA1140466A (fi)
CH (1) CH646604A5 (fi)
DE (1) DE3100191A1 (fi)
DK (1) DK6181A (fi)
ES (2) ES498369A0 (fi)
FI (1) FI76927C (fi)
FR (1) FR2473308B1 (fi)
GB (1) GB2067072B (fi)
GR (1) GR73843B (fi)
IE (1) IE50806B1 (fi)
IN (1) IN151913B (fi)
IT (1) IT1221041B (fi)
LU (1) LU83052A1 (fi)
NL (1) NL8100037A (fi)
NO (1) NO156153C (fi)
NZ (1) NZ195933A (fi)
SE (1) SE447450B (fi)
ZA (1) ZA81136B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
EP0230647B1 (en) * 1985-12-27 1993-03-31 Sumitomo Pharmaceuticals Company, Limited Method for producing a sustained release formulation
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CA1316110C (en) * 1987-02-27 1993-04-13 Peter Lloyd Oren Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (fi) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
NO156153C (no) 1987-08-05
AU6597681A (en) 1981-07-16
NL8100037A (nl) 1981-08-03
NZ195933A (en) 1982-11-23
JPS56103110A (en) 1981-08-18
ATA5481A (de) 1983-10-15
IE810036L (en) 1981-07-11
DE3100191C2 (fi) 1988-09-01
SE8100104L (sv) 1981-07-12
FI76927C (fi) 1989-01-10
ES8205353A1 (es) 1982-06-01
FI76927B (fi) 1988-09-30
AU542824B2 (en) 1985-03-14
DK6181A (da) 1981-07-12
BE886998A (fr) 1981-07-08
ES8301629A1 (es) 1982-12-16
FR2473308A1 (fr) 1981-07-17
IN151913B (fi) 1983-09-03
GB2067072A (en) 1981-07-22
DE3100191A1 (de) 1981-12-10
NO156153B (no) 1987-04-27
AT374681B (de) 1984-05-25
ZA81136B (en) 1982-01-27
CH646604A5 (fr) 1984-12-14
IE50806B1 (en) 1986-07-23
IT8147537A0 (it) 1981-01-09
IT1221041B (it) 1990-06-21
NO810062L (no) 1981-07-13
GB2067072B (en) 1983-08-10
FI810056L (fi) 1981-07-12
ES509179A0 (es) 1982-12-16
SE447450B (sv) 1986-11-17
GR73843B (fi) 1984-05-07
FR2473308B1 (fr) 1985-07-19
CA1140466A (en) 1983-02-01
ES498369A0 (es) 1982-06-01

Similar Documents

Publication Publication Date Title
LU83052A1 (fr) Composition pharmaceutique a effet prolonge et son procede de preparation
CA2825053C (fr) Granules effervescents d'acide gamma-hydroxybutyrique
FI87424C (fi) Foerfarande foer framstaellning av fasta nifedipinpreparat, som biologiskt laett kan tillgodogoeras och som har en foerdroejd effekt
EP0330532B1 (fr) Nouvelle forme galénique du fénofibrate
WO2010055260A1 (fr) Nouvelle composition à base d'acide gamma-hydroxybutyrique
EP0256933A1 (fr) Procédé de préparation d'un médicament à base de fénofibrate, médicament obtenu par ce procédé
WO1988006457A1 (en) Medicinal composition containing albumin as carrier and process for its preparation
JP2003055203A (ja) ユビキノン含有製剤
CH647676A5 (fr) Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
JPS63162627A (ja) 徐放性医薬製剤
JPH0413625A (ja) ビタミンｄ↓３誘導体含有固形製剤組成物
FR2541287A1 (fr) Preparation stable administrable par voie orale de macrolides antibiotiques et procede pour les stabiliser
CN112716903B (zh) 一种氨氯地平干混悬剂及其制备方法
JP2849047B2 (ja) ジクロフェナクナトリウム持続性製剤およびその製法
FR2529784A1 (fr) Medicament a liberation retardee contenant du 1-(p-(isopropylthio)-phenyl)-2-octylamino-1-propanol
JP2004507479A (ja) 粒状化可能な混合物の調製方法及びカルニチン・マグネシウム・ヒドロキシクエン酸塩
WO2003059323A2 (de) Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii
JPS6087216A (ja) 一定放出性固体投薬形インドメタシン組成物および関節炎その他の炎症性状態の治療法
EP0483320B1 (fr) Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation
JP3992764B2 (ja) イブジラスト含有持続性製剤およびその製法
CN115531338B (zh) 一种非布司他片及其制备方法
JP2008074838A (ja) グルコシルヘスペリジン含有組成物
JPH11322584A (ja) ベザフィブラート徐放性製剤
RU2233155C1 (ru) Способ получения витаминного комплекса в виде драже
EP4376816A1 (fr) Procede de drageification ameliore comprenant un amidon hydrolyse et fonctionnalise